William M. LeFor

754 total citations
27 papers, 526 citations indexed

About

William M. LeFor is a scholar working on Transplantation, Public Health, Environmental and Occupational Health and Surgery. According to data from OpenAlex, William M. LeFor has authored 27 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Transplantation, 10 papers in Public Health, Environmental and Occupational Health and 8 papers in Surgery. Recurrent topics in William M. LeFor's work include Renal Transplantation Outcomes and Treatments (17 papers), Organ Donation and Transplantation (7 papers) and Renal Diseases and Glomerulopathies (7 papers). William M. LeFor is often cited by papers focused on Renal Transplantation Outcomes and Treatments (17 papers), Organ Donation and Transplantation (7 papers) and Renal Diseases and Glomerulopathies (7 papers). William M. LeFor collaborates with scholars based in United States. William M. LeFor's co-authors include Fred Sanfilippo, William K. Vaughn, Everett K. Spees, Dawn R. Wagenknecht, Dana L. Shires, John A. McIntyre, Jimmy A. Light, John R. Ackermann, Juan C. Scornik and Mayra Lopez‐Cepero and has published in prestigious journals such as New England Journal of Medicine, The Journal of Immunology and Transplantation.

In The Last Decade

William M. LeFor

27 papers receiving 498 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William M. LeFor United States 12 322 220 118 109 80 27 526
Janto Surachno Netherlands 15 271 0.8× 221 1.0× 68 0.6× 118 1.1× 105 1.3× 21 583
Marylise Fort France 11 318 1.0× 148 0.7× 106 0.9× 125 1.1× 79 1.0× 24 521
Christopher M. Bearden United States 9 262 0.8× 176 0.8× 105 0.9× 165 1.5× 30 0.4× 9 504
Anne Modesto France 14 342 1.1× 200 0.9× 207 1.8× 86 0.8× 54 0.7× 31 855
N.L. Reinsmoen United States 13 534 1.7× 399 1.8× 131 1.1× 263 2.4× 80 1.0× 47 837
F Kriaa France 14 249 0.8× 175 0.8× 59 0.5× 126 1.2× 50 0.6× 38 623
T. Shah United States 11 528 1.6× 315 1.4× 88 0.7× 129 1.2× 137 1.7× 17 851
V.R. Peddi United States 13 363 1.1× 208 0.9× 70 0.6× 54 0.5× 75 0.9× 33 546
J. Goldberg Argentina 13 215 0.7× 244 1.1× 54 0.5× 63 0.6× 119 1.5× 23 650
Brendan Clark United Kingdom 13 211 0.7× 173 0.8× 39 0.3× 217 2.0× 62 0.8× 33 567

Countries citing papers authored by William M. LeFor

Since Specialization
Citations

This map shows the geographic impact of William M. LeFor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William M. LeFor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William M. LeFor more than expected).

Fields of papers citing papers by William M. LeFor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William M. LeFor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William M. LeFor. The network helps show where William M. LeFor may publish in the future.

Co-authorship network of co-authors of William M. LeFor

This figure shows the co-authorship network connecting the top 25 collaborators of William M. LeFor. A scholar is included among the top collaborators of William M. LeFor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William M. LeFor. William M. LeFor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leone, John P., et al.. (2011). The acceptable reactive crossmatch (ARC), post-transplant monitoring, and their impact on kidney transplantation: a single center experience.. PubMed. 373–9. 1 indexed citations
2.
Pereira, Shalini, Susan Perkins, William M. LeFor, et al.. (2011). Donor-specific antibody against denatured HLA-A1: Clinically nonsignificant?. Human Immunology. 72(6). 492–498. 61 indexed citations
3.
Leech, S. H., Mayra Lopez‐Cepero, William M. LeFor, et al.. (2006). Management of the sensitized cardiac recipient: the use of plasmapheresis and intravenous immunoglobulin. Clinical Transplantation. 20(4). 476–484. 51 indexed citations
4.
Wagenknecht, Dawn R., et al.. (2000). Risk of early renal allograft failure is increased for patients with antiphospholipid antibodies. Transplant International. 13(0). S78–S81. 16 indexed citations
5.
Wagenknecht, Dawn R., et al.. (2000). Risk of early renal allograft failure is increased for patients with antiphospholipid antibodies. Transplant International. 13(S1). S78–S81. 9 indexed citations
6.
Wagenknecht, Dawn R., et al.. (1999). ANTIPHOSPHOLIPID ANTIBODIES ARE A RISK FACTOR FOR EARLY RENAL ALLOGRAFT FAILURE. Transplantation. 68(2). 241–246. 62 indexed citations
7.
Wang, J., et al.. (1997). New Alleles of the HLA-B15 Family. Human Immunology. 55(2). 184–189. 6 indexed citations
8.
LeFor, William M., John R. Ackermann, Victor Bowers, et al.. (1996). Flow cytometry crossmatching and primary cadaver kidney graft outcome: relevance of T and B cell targets, historic sera and autologous controls. Clinical Transplantation. 10(6pt2). 601–606. 24 indexed citations
9.
LeFor, William M., et al.. (1995). Hemoconcentration prior to serology testing in hemodiluted cadaver bone and tissue donors. Clinical Transplantation. 9(4). 297–300. 11 indexed citations
10.
Barger, Bruce O., et al.. (1992). POSITIVE CROSSMATCHES AGAINST MANDATORILY SHARED KIDNEYS. Transplantation. 54(2). 254–262. 3 indexed citations
11.
Scornik, Juan C., William M. LeFor, J Cicciarelli, et al.. (1992). HYPERACUTE AND ACUTE KIDNEY GRAFT REJECTION DUE TO ANTIBODIES AGAINST B CELLS. Transplantation. 54(1). 61–64. 65 indexed citations
12.
Kahana, Lawrence, John R. Ackermann, William M. LeFor, et al.. (1990). Uses of orthoclone OKT3 for prophylaxis of rejection and induction in initial nonfunction in kidney transplantation.. PubMed. 22(4). 1755–8. 7 indexed citations
13.
Scornik, Juan C. & William M. LeFor. (1987). ANTIBODIES TO CROSSREACTIVE HLA ANTIGENS. Transplantation. 43(2). 235–239. 9 indexed citations
14.
Sanfilippo, Fred, William K. Vaughn, William M. LeFor, & Everett K. Spees. (1986). MULTIVARIATE ANALYSIS OF RISK FACTORS IN CADAVER DONOR KIDNEY TRANSPLANTATION. Transplantation. 42(1). 28–34. 47 indexed citations
15.
Sanfilippo, Fred, et al.. (1985). The influence of crossmatch test sensitivity on outcome in cadaver renal transplantation. Transplantation Proceedings. 17(6). 2454–2456. 1 indexed citations
16.
Sanfilippo, Fred, W. K. Vaughn, William M. LeFor, & Everett K. Spees. (1985). The relative influence of variables associated with cadaver renal transplant outcome. Transplantation Proceedings. 17(6). 2256–2258. 3 indexed citations
17.
LeFor, William M., et al.. (1985). USE OF SEOPF REGIONAL CROSSMATCH TRAYS TO SHARE KIDNEYS FOR SENSITIZED PATIENTS; Local Experience of Three Centers. Transplantation. 40(6). 637–641. 7 indexed citations
18.
Sanfilippo, Fred, William K. Vaughn, Everett K. Spees, Jimmy A. Light, & William M. LeFor. (1984). Benefits of HLA-A and HLA-B Matching on Graft and Patient Outcome after Cadaveric-Donor Renal Transplantation. New England Journal of Medicine. 311(6). 358–364. 48 indexed citations
19.
Williams, George M., et al.. (1984). REASONS WHY KIDNEYS REMOVED FOR TRANSPLANTATION ARE NOT TRANSPLANTED IN THE UNITED STATES. Transplantation. 38(6). 691–694. 7 indexed citations
20.
LeFor, William M. & Dierk Bauer. (1970). Relative Concentrations of IgM and IgG Antibodies during the Primary Response. The Journal of Immunology. 104(5). 1276–1286. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Janto Surachno Breakdown of academic impact, for papers by Marylise Fort Breakdown of academic impact, for papers by Christopher M. Bearden Breakdown of academic impact, for papers by Anne Modesto Breakdown of academic impact, for papers by N.L. Reinsmoen Breakdown of academic impact, for papers by F Kriaa Breakdown of academic impact, for papers by T. Shah Breakdown of academic impact, for papers by V.R. Peddi Breakdown of academic impact, for papers by J. Goldberg Breakdown of academic impact, for papers by Brendan Clark
Rankless by CCL
2026